skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: ERα is a negative regulator of PD-L1 gene transcription in breast cancer

Journal Article · · Biochemical and Biophysical Research Communications
; ; ; ;  [1];  [2];  [1]
  1. Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032 (China)
  2. Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040 (China)

Highlights: • PD-L1 mRNA level is much lower in ERα-positive breast cancer cell lines. • E2 treatment inhibits PD-L1 gene transcription in ERα-positive MCF7 cells. • Ectopic expression of ERα down-regulates PD-L1 gene expression in ERα-negative MDA-MB-231 cells. • ERα expression is negatively correlated with PD-L1 expression in ERα-positive breast cancer. The programmed death-ligand 1 (PD-L1) expression by tumors results in potent antitumor immune suppression through binding to programmed death-1 (PD-1) on T cells and subsequent inhibition of T cells activity. Although recent pathological studies have shown that PD-L1 is actively expressed in certain ERα-negative breast cancer, little is known about whether ER signaling regulates PD-L1 gene expression. Here, we investigated the relationship between ERα and PD-L1 in breast cancer. Analysis of Comprehensive Cell Line Encyclopedia (CCLE) data showed that the average mRNA level of PD-L1 in ERα-positive breast cancer cell lines was significantly lower than that in ERα-negative breast cancer cell lines. E2 treatment inhibited PD-L1 mRNA expression in hormone-depleted ERα-positive MCF7 cells. Moreover, ectopic expression of ERα in triple-negative MDA-MB-231 cells reduced PD-L1 mRNA and protein expression. Consistently, analysis of The Cancer Genome Atlas (TCGA) data revealed an inverse correlation between ERα and PD-L1 expression in ERα-positive breast cancer. Taken together, our results identify ERα as a negative regulator of PD-L1 gene transcription in breast cancer cells, suggesting that ERα loss-of-function may facilitate the immune evasion of breast cancer cells via up-regulation of PD-L1.

OSTI ID:
23107841
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 505, Issue 1; Other Information: Copyright (c) 2018 Elsevier Inc. All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer
Journal Article · Fri Aug 15 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:23107841

Benzimidazoles diminish ERE transcriptional activity and cell growth in breast cancer cells
Journal Article · Fri Aug 08 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:23107841

Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator
Journal Article · Fri Sep 26 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:23107841